IDENTIFICATION OF OSTEOBLAST CELLS DIFFERENTIATION AND BONE TUMOR MARKERS AND USES THEREOF

摘要

The present invention discloses a method for the diagnosis of a metabolic bone disease, and/or for assessing osteoporotic fracture risk and/or for the monitoring of therapeutic efficacy of a metabolic bone disease drug in a subject and a method for the diagnosis of bone tumor including the identification and quantification of bone cell or bone tumor specific proteins.